REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Endurance RP Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Scientific Research and Development Services | Management of Companies and Enterprises
Full name: Endurance RP Limited Profile Updated: January 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Regent Pacific Group Limited is mainly engaged in exploration and mining of coal and other natural resources through its subsidiaries in Yunnan province of China and Western Australia. The company was founded in 1991.

Headquarters
8th Floor, Henley Building, 5 Queen＇s Road Central, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the Endurance RP Limited report to view the information.

Website: http://www.endurancerp.com

Basic Information
Total Employees:
Purchase the Endurance RP Limited report to view the information.
Outstanding Shares:
Purchase the Endurance RP Limited report to view the information.
Registered Capital:
Purchase the Endurance RP Limited report to view the information.
Financial Auditors:
Purchase the Endurance RP Limited report to view the information.
Incorporation Date:
May 07, 1991
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
56.56%
Subsidiaries
Amerinvest Coal Industry Holding Company Limited
100%
Deep Longevity Limited
100%
Deep Longevity, Inc (Cayman Islands)
100%
Company Performance
Financial values in the chart are available after Endurance RP Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
530.77%▲
Total operating revenue
1346.15%▲
Operating profit (EBIT)
28.88%▲
EBITDA
69.66%▲
Net Profit (Loss) for the Period
39.19%▲
Total assets
-59.16%▼
Total equity
-40.81%▼
Operating Profit Margin (ROS)
141754.6%▲
Net Profit Margin
139446.25%▲
Return on Equity (ROE)
-2.84%▼
Debt to Equity Ratio
-72.15%▼
Quick Ratio
1.54%▲
Cash Ratio
1.51%▲

Similar companies

Sinopharm Group Company Limited
 
China Resources Pharmaceutical Group Ltd
Fosun International Limited
 
CSPC Pharmaceutical Group Limited
Sino Biopharmaceutical Limited
 
China Traditional Chinese Medicine Holdings Co. Limited
Zhaoke Ophthalmology Limited (Hong Kong) (兆科眼科有限公司 (香港))
 
Sirnaomics Limited
SinoMab BioScience Limited
 
Laekna, Inc.
Kintor Pharmaceutical Limited (Hong Kong) (开拓药业有限公司 (香港))
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo